Prasugrel (10 mg) is an effective antiplatelet agent found in PERUSUGREL-10, a prescription drug intended to prevent blood clot formation in people at risk of cardiovascular events. As a member of the thienopyridine antiplatelet medication family, prasugrel lowers the risk of heart attacks, strokes, and problems from stents by preventing platelet aggregation.

Patients experiencing acute coronary syndrome (ACS) or those undergoing percutaneous coronary intervention (PCI), sometimes referred to as angioplasty, are specifically administered this medication. PERUSUGREL-10 helps sustain normal blood flow and shields the heart from major problems by preventing platelets from adhering to one another.

Uses

PERUSUGREL-10 is primarily used for cardiovascular protection in patients with high risk of clot formation:

• Acute coronary syndrome (ACS), including unstable angina and myocardial infarction

• Prevention of blood clots in patients undergoing angioplasty or stent placement

• Post-percutaneous coronary intervention (PCI) therapy

• Secondary prevention of heart attack in high-risk individuals

• Combination therapy with aspirin to enhance antiplatelet effects

Its use is guided by cardiologists to ensure safe and effective management of cardiovascular diseases.

Benefits

PERUSUGREL-10 offers multiple benefits for patients with cardiovascular conditions:

1. Effective Blood Clot Prevention

By inhibiting platelet aggregation, PERUSUGREL-10 reduces the risk of dangerous clots that can cause heart attacks and strokes.

2. Supports Post-Angioplasty Recovery

Used after stent placement, it helps prevent stent thrombosis, a serious complication of coronary interventions.

3. Improves Heart Health Outcomes

Clinical studies show that prasugrel therapy decreases the incidence of major cardiovascular events in patients with ACS.

4. Rapid Onset of Action

Prasugrel acts quickly to inhibit platelet function, providing timely protection during high-risk periods.

5. Combination Therapy Advantage

When used alongside aspirin, PERUSUGREL-10 offers dual antiplatelet therapy, which is standard in ACS management.

Dosage

The dosage of PERUSUGREL-10 must be prescribed and monitored by a cardiologist or healthcare professional.

General Dosage Guidelines

• Typical dose: 10 mg once daily

• Administration: Take orally with water, with or without food

• Duration: Often prescribed for several months post-angioplasty or as advised for long-term therapy

• Combination: Frequently used with low-dose aspirin for dual antiplatelet therapy

Important Instructions

• Take at the same time each day for consistent effect

• Do not skip doses or stop therapy without consulting a doctor

• Regular follow-ups and blood tests may be required to monitor platelet function and overall safety

Side Effects

Like all antiplatelet medications, PERUSUGREL-10 may cause side effects, though not all patients experience them.

Common Side Effects

• Easy bruising

• Nosebleeds

• Minor bleeding from gums

• Dizziness or headache

Serious Side Effects (Less Common)

• Severe or prolonged bleeding

• Gastrointestinal bleeding

• Allergic reactions (rash, swelling, itching)

• Low platelet count (thrombocytopenia)

Immediate medical attention is required if there is uncontrolled bleeding or signs of severe allergic reaction.

Precautions and Warnings

Before taking PERUSUGREL-10, the following precautions should be considered:

• Active bleeding: Should not be taken in patients with active bleeding disorders

• Surgery or dental procedures: Inform your doctor, as therapy may need adjustment

• Kidney or liver impairment: Use with caution, under medical supervision

• Pregnancy and breastfeeding: Only take if prescribed by a doctor

• Drug interactions: Inform the doctor about all other medications, including anticoagulants and NSAIDs

Careful monitoring is essential to balance clot prevention and bleeding risk.

Conclusion

PERUSUGREL-10, containing Prasugrel 10 mg, is a clinically proven antiplatelet therapy for the prevention of blood clots, particularly in patients with acute coronary syndrome or those undergoing angioplasty. By inhibiting platelet aggregation, it significantly reduces the risk of heart attacks, strokes, and stent-related complications.